 |
市场调查报告书
商品编码
1147464
脂质市场规模、份额和趋势分析报告：按产品（甘油三酯、磷脂）、阶段（临床、临床前）、应用、地区、细分市场预测 2022-2030 年Lipid Market Size, Share & Trends Analysis Report By Product (Triglycerides, Phospholipids), By Phase (Clinical, Pre-clinical), By Application, By Region, And Segment Forecasts, 2022 - 2030 |
||||||
脂质市场的成长与趋势
根据 Grandview Research 的一份新报告，到 2030 年，全球脂质市场预计将达到 128.5 亿美元。这种增长主要是由脂质在功能性食品、功能性饮料和膳食补充剂生产中越来越多的利用所推动的，因为它们具有丰富的特性，例如高能量。在人体中，脂质用于保护神经细胞、支持细胞和其他重要功能，为身体提供维生素，并产生睪丸激素、雌激素和皮质醇等激素，预计在全球范围内会上升。
可电离脂质由于其治疗剂的高递送效率而在製药行业中得到越来越多的使用和增长。在 COVID-19 期间，它被广泛用于将 mRNA 转移到细胞中。上述因素归因于脂质纳米颗粒市场的增长。
亚太地区的人口增长已成为该地区产业稳定增长的关键因素。消费品、保健品、食品和饮料等消费量的增加正在增加该地区对化学成分的需求。该地区还是嘉吉、巴斯夫和嘉里集团等大公司的所在地，这些公司生产大量油脂以满足当地需求。
中国是世界上人口最多的国家，人口约14.2亿。中国的人口增长正在推动该国食品、饮料和营养补充剂的消费。中国消费者越来越多地转向含有有益健康成分的功能性饮料。由于这些因素，预计未来几年中国食品和饮料製造业对脂质的需求将会增长。
由于植物和动物等原材料的现成供应，全球用于脂肪酸开发的原材料供应商数量正在增加。大量的原材料供应商加剧了市场竞争，导致原材料价格和可用性的变化。
COVID-19 的传播对全球脂质市场的增长产生了积极影响。大流行期间的全球健康危机刺激了对营养补充剂和药品的需求。此外，製药行业的消费，尤其是 COVID-19 疫苗的配製，在大流行期间增加了需求。
脂质市场报告要点
甘油三酯是增长最快的产品类别，从 2022 年到 2030 年的复合年增长率为 8.9%。这是由于其在食品和饮料行业越来越多地用于生产功能性食品和饮料。
由于人口增长导致食品消费增加，食品和饮料应用是增长最快的部分，从 2022 年到 2030 年的复合年增长率为 8.9%。
亚太地区是增长最快的地区，复合年增长率为 9.2%，因为人口增长推动了中国和印度等国家/地区功能性食品、营养保健品和药品的消费量增加。
各国政府对植物和动物来源的脂质的生产和消费的监管预计将在不久的将来阻碍市场增长。
随着俄罗斯和乌克兰之间地缘政治衝突的持续，石油、能源、天然气等的成本不断上升。这种情况导致了脂肪生产原料价格的上涨。
内容
第 1 章调查方法及范围
- 市场细分和范围
- 市场定义
- 信息采购
- 购买的数据库
- GVR 内部数据库
- 次要信息
- 第三方视角
- 初步调查
- 主要资讯
- 资讯分析
- 数据分析模型
- 市场形成和数据可视化
- 验证和发布数据
- 调查范围和假设
第 2 章执行摘要
- 市场展望
- 按细分市场预测
- 竞争考虑
第 3 章市场变量、趋势和范围
- 市场系列展望
- 全球脂质市场
- 描绘渗透率和增长前景
- 行业价值链分析
- 原材料趋势
- 製造和技术趋势
- 销售渠道分析
- 供需分析
- 供应
- 要求
- 监管框架
- 市场动态
- 市场驱动因素的影响分析
- 日益增长的健康问题增加了全球对膳食补充剂的需求
- 由于其卓越的功能特性，脂质在各种应用中的使用越来越多
- 市场约束影响分析
- 原材料价格波动
- 行业问题
- 市场驱动因素的影响分析
- COVID-19 对行业的影响
- 东欧地缘政治争端对行业的影响
- 生产成本分析
- 纳米脂质在药物中的潜力
- 商业环境分析
- 波特的分析
- PESTEL 分析
第 4 章脂质市场：产品估计和趋势分析
- 2021 年和 2030 年产品趋势分析和市场份额（千吨）（百万美元）
- 离子脂质（脂质纳米颗粒）
- mRNA
- 小干扰RNA
- 其他
- 甘油三酯
- 鞘脂
- 磷脂
- 其他（中性脂质、聚乙二醇化脂质）
- 离子脂质（脂质纳米颗粒）
第 5 章脂质市场：阶段估计和趋势分析
- 相变分析和市场份额，2021 年和 2030 年（千吨）（百万美元）
- 临床阶段
- 临床前阶段
- 其他
第 6 章脂质市场：应用估计和趋势分析
- 应用变化分析和市场份额，2021 年和 2030 年（千吨）（百万美元）
- 医药
- 疫苗和药物
- 科学研究
- 营养和补充剂
- 食品和饮料
- 其他
- 医药
第 7 章脂质市场：区域估计和趋势分析
- 2021 年和 2030 年各地区的趋势分析和市场份额（千吨）（百万美元）
- 北美
- 美国
- 加拿大
- 墨西哥
- 欧洲
- 德国
- 英国
- 法国
- 西班牙
- 意大利
- 比利时
- 俄罗斯
- 土耳其
- 亚太地区
- 中国
- 印度
- 日本
- 澳大利亚
- 印度尼西亚
- 泰国
- 菲律宾
- 马来西亚
- 越南
- 韩国
- 拉丁美洲
- 巴西
- 阿根廷
- 哥伦比亚
- 中东和非洲
- 沙特阿拉伯
- 南非
- 阿拉伯联合酋长国
- 埃及
- 尼日利亚
- 北美
第 8 章脂质市场 - 竞争格局
- 主要市场进入者的近期趋势和影响分析
- 公司/竞争对手分类（主要创新者、市场领导者、初创企业）
- 供应商情况
- 原材料供应商名单
- 製造商列表
- 主要分销商和渠道合作伙伴列表
- 潜在最终用户列表
- 2021 年主要参与者的市场定位分析
- 战略框架
第 9 章公司简介
- Evonik Industries AG
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Precision Nanosystems
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Merck Kgaa
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Genevant Sciences
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Exelead
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Avanti Polar Lipids
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Nippon Fine Chemicals Co. Ltd.
- 公司简介
- 财务业绩
- 产品基准
- Lipoid Gmbh
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Cargill, Incorporated
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- BASF SE
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Archer Daniels Midland Company（ADM）
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Koninklijke DSM NV
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Kerry Group Plc
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Nordic Naturals, Inc.
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Clover Corporation
- 公司简介
- 财务业绩
- 产品基准
- Croda International Plc
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Lipoid Kosmetik AG
- 公司简介
- 财务业绩
- 产品基准
- 战略举措
- Omega Protein Corporation
- 公司简介
- 财务业绩
- 产品基准
Lipid Market Growth & Trends:
The global lipid market is expected to reach USD 12.85 billion by 2030, as per the new report by Grand View Research, Inc. The growth is majorly driven by the rising utilization of lipids in the production of functional food, functional beverages, and dietary supplements owing to their rich properties such as high in energy. In the human body, lipids are used for protecting nerve cells, supporting cells and other essential functions, supplying vitamins to the body, producing hormones such as testosterone, estrogen, and cortisol, etc., which is expected to propel the demand for lipids over the projected years globally.
Ionizable lipids have been growing due to its increasing use in the pharmaceutical industry due to their high efficiency in delivering therapeutics. During COVID-19, it was widely used for transferring mRNA to cells. These above-mentioned factors are attributed to the growth of the lipid nanoparticle market.
Population growth in the Asia Pacific has been a key factor for the steady pace of growth of industries in the region. Rising consumption of consumer products, healthcare products, food & beverages products, and others has augmented the demand for chemical ingredients in the region. In addition, the region has the presence of major market players, such as Cargill Incorporated, BASF SE, and Kerry Group plc, which have been producing lipids in large volumes to fulfill the requirements in the region.
China is the most populous country in the world with population of approximately 1.42 billion. Rising population of China has propelled the consumption of food & beverages and nutritional supplements in the country. Chinese consumers are more inclined toward functional beverages that contain ingredients beneficial to health. This factor is expected to augment the demand for lipids in the manufacturing of food & beverages in China over the projected years.
The easy availability of sources such as plants and animals has resulted in an increased number of suppliers of raw materials used for developing fatty acids across the world. This high number of raw material suppliers results in intense competition in the market, thereby leading to an inconsistency in prices and availability of raw materials.
The spread of COVID-19 positively impacted the growth of the lipid market across the world. The massive health crisis worldwide during the pandemic fueled the demand for dietary supplements and medicines. Furthermore, its consumption in the pharmaceuticals industry, particularly for the formulation of the COVID-19 vaccines, enhanced its demand during the pandemic.
Lipid Market Report Highlights:
- Triglycerides is the fastest growing product segment with a CAGR of 8.9% from 2022 to 2030 on the account of its rising application in food & beverages industry for the formulation of functional food and functional beverages
- Food & beverages application is the fastest growing segment with a CAGR of 8.9% from 2022 to 2030 owing to the increasing consumption of food on the account of rising population
- Asia Pacific is the fastest growing region with a CAGR of 9.2% because of the increasing consumption in functional food, dietary supplements, and medicines in the countries like China and India owing to the increasing population
- The presence of government regulations related to the production and consumption of lipids in different countries owing to the usage of plants and animals for developing them is anticipated to hinder the growth of the market over the foreseeable future
- The ongoing European geopolitical conflict between Russia and Ukraine has led to a hike in the costs of oil, energy, natural gas, etc. This situation has resulted in the price hike of raw materials for lipid production
Table of Contents
Chapter 1 Methodology And Scope
- 1.1 Market Segmentation & Scope
- 1.2 Market Definition
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Third Party Perspective
- 1.3.5 Primary Research
- 1.3.6 Primary Sources
- 1.4 Information Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Data Visualization
- 1.6 Data Validation & Publishing
- 1.7 Research Scope And Assumptions
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segmental Outlook
- 2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Global Lipid Market
- 3.2 Penetration & Growth Prospect Mapping
- 3.3 Industry Value Chain Analysis
- 3.3.1 Raw Material Trends
- 3.3.2 Manufacturing/Technology Trends
- 3.3.3 Sales Channel Analysis
- 3.4 Supply-Demand Analysis
- 3.4.1 Supply
- 3.4.2 Demand
- 3.5 Regulatory Framework
- 3.6 Price Trend Analysis, 2018 - 2030
- 3.7 Market Dynamics
- 3.7.1 Market Driver Impact Analysis
- 3.7.1.1 Growing Global Demand For Dietary Supplements Owing To Rising Health Concerns
- 3.7.2 Increasing Usage Of Lipids In Various Applications Due To Their Superior Functional Properties
- 3.7.3 Market Restraint Impact Analysis
- 3.7.3.1 Volatile Feedstock Prices
- 3.7.4 Industry Challenges
- 3.7.1 Market Driver Impact Analysis
- 3.8 Impact Of COVID-19 On The Industry
- 3.9 Impact Of Eastern European Geopolitical Conflict On The Industry
- 3.10 Production Cost Analysis
- 3.11 Opportunities Of Nano Lipids In Pharmaceutical
- 3.12 Business Environment Analysis
- 3.12.1 Porter's Analysis
- 3.12.2 PESTEL Analysis
Chapter 4 Lipid Market: Product Estimates & Trend Analysis
- 4.1 Product Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 4.1.1 Ionizable Lipids (Lipid Nano Particles)
- 4.1.1.1 mRNA
- 4.1.1.2 siRNA
- 4.1.1.3 Others
- 4.1.2 Triglycerides
- 4.1.3 Sphingolipids
- 4.1.4 Phospholipids
- 4.1.5 Others (Neutral Lipids, Pegylated Lipids)
- 4.1.1 Ionizable Lipids (Lipid Nano Particles)
Chapter 5 Lipid Market: Phase Estimates & Trend Analysis
- 5.1 Phase Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 5.1.1 Clinical Phase
- 5.1.2 Pre-Clinical Phase
- 5.1.3 Others
Chapter 6 Lipid Market: Application Estimates & Trend Analysis
- 6.1 Application Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 6.1.1 Pharmaceuticals
- 6.1.1.1 Vaccines And Drugs
- 6.1.1.2 Scientific Research
- 6.1.2 Nutrition & Supplements
- 6.1.3 Food & Beverages
- 6.1.4 Others
- 6.1.1 Pharmaceuticals
Chapter 7 Lipid Market: Regional Estimates & Trend Analysis
- 7.1 Regional Movement Analysis & Market Share, 2021 & 2030 (Kilotons) (USD Million)
- 7.1.1 North America
- 7.1.1.1 U.S.
- 7.1.1.2 Canada
- 7.1.1.3 Mexico
- 7.1.2 Europe
- 7.1.2.1 Germany
- 7.1.2.2 UK
- 7.1.2.3 France
- 7.1.2.4 Spain
- 7.1.2.5 Italy
- 7.1.2.6 Belgium
- 7.1.2.7 Russia
- 7.1.2.8 Turkey
- 7.1.3 Asia Pacific
- 7.1.3.1 China
- 7.1.3.2 India
- 7.1.3.3 Japan
- 7.1.3.4 Australia
- 7.1.3.5 Indonesia
- 7.1.3.6 Thailand
- 7.1.3.7 Philippines
- 7.1.3.8 Malaysia
- 7.1.3.9 Vietnam
- 7.1.3.10 South Korea
- 7.1.4 Central & South America
- 7.1.4.1 Brazil
- 7.1.4.2 Argentina
- 7.1.4.3 Colombia
- 7.1.5 Middle East & Africa
- 7.1.5.1 Saudi Arabia
- 7.1.5.2 South Africa
- 7.1.5.3 U.A.E.
- 7.1.5.4 Egypt
- 7.1.5.5 Nigeria
- 7.1.1 North America
Chapter 8 Lipid Market - Competitive Landscape
- 8.1 Recent Developments & Impact Analysis, By Key Market Participants
- 8.2 Company/Competition Categorization (Key Innovators, Market Leaders, And Emerging Players)
- 8.3 Vendor Landscape
- 8.3.1 List Of Raw Material Suppliers
- 8.3.2 List Of Manufacturers
- 8.3.3 List Of Key Distributors And Channel Partners
- 8.3.4 List Of Potential Endusers
- 8.4 Key Company Market Positioning Analysis, 2021
- 8.5 Strategic Framework
Chapter 9 Company Profiles
- 9.1 Evonik Industries AG
- 9.1.1 Company Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Benchmarking
- 9.1.4 Strategic Initiatives
- 9.2 Precision Nanosystems
- 9.2.1 Company Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Benchmarking
- 9.2.4 Strategic Initiatives
- 9.3 Merck Kgaa
- 9.3.1 Company Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Benchmarking
- 9.3.4 Strategic Initiatives
- 9.4 Genevant Sciences
- 9.4.1 Company Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Benchmarking
- 9.4.4 Strategic Initiatives
- 9.5 Exelead
- 9.5.1 Company Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Benchmarking
- 9.5.4 Strategic Initiatives
- 9.6 Avanti Polar Lipids
- 9.6.1 Company Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Benchmarking
- 9.6.4 Strategic Initiatives
- 9.7 Nippon Fine Chemicals Co. Ltd.
- 9.7.1 Company Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Benchmarking
- 9.8 Lipoid Gmbh
- 9.8.1 Company Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Benchmarking
- 9.8.4 Strategic Initiatives
- 9.9 Cargill, Incorporated
- 9.9.1 Company Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Benchmarking
- 9.9.4 Strategic Initiatives
- 9.10 BASF SE
- 9.10.1 Company Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Benchmarking
- 9.10.4 Strategic Initiatives
- 9.11 Archer Daniels Midland Company (ADM)
- 9.11.1 Company Overview
- 9.11.2 Financial Performance
- 9.11.3 Product Benchmarking
- 9.11.4 Strategic Initiatives
- 9.12 Koninklijke DSM N.V.
- 9.12.1 Company Overview
- 9.12.2 Financial Performance
- 9.12.3 Product Benchmarking
- 9.12.4 Strategic Initiatives
- 9.13 Kerry Group Plc
- 9.13.1 Company Overview
- 9.13.2 Financial Performance
- 9.13.3 Product Benchmarking
- 9.13.4 Strategic Initiatives
- 9.14 Nordic Naturals, Inc.
- 9.14.1 Company Overview
- 9.14.2 Financial Performance
- 9.14.3 Product Benchmarking
- 9.14.4 Strategic Initiatives
- 9.15 Clover Corporation
- 9.15.1 Company Overview
- 9.15.2 Financial Performance
- 9.15.3 Product Benchmarking
- 9.16 Croda International Plc
- 9.16.1 Company Overview
- 9.16.2 Financial Performance
- 9.16.3 Product Benchmarking
- 9.16.4 Strategic Initiatives
- 9.17 Lipoid Kosmetik AG
- 9.17.1 Company Overview
- 9.17.2 Financial Performance
- 9.17.3 Product Benchmarking
- 9.17.4 Strategic Initiatives
- 9.18 Omega Protein Corporation
- 9.18.1 Company Overview
- 9.18.2 Financial Performance
- 9.18.3 Product Benchmarking
List of Tables
- Table 1 Key Company/Competition Categorization
- Table 2 List Of Key Raw Material Suppliers
- Table 3 List Of Manufacturers
- Table 4 List Of Key Distributors And Channel Partners
- Table 5 List Of Potential End Users
List of Figures
- Fig. 1 Lipid Market Segmentation
- Fig. 2 Information Procurement
- Fig. 3 Primary Research Pattern
- Fig. 4 Data Analysis Models
- Fig. 5 Market Formulation And Validation
- Fig. 6 Data Validating & Publishing
- Fig. 7 Market Snapshot, 2021
- Fig. 8 Structural Adhesives Market, Segmental Outlook, 2021 (USD Million)
- Fig. 9 Global Lipid Market Volume & Revenue, 2018 - 2030 (Kilotons) (USD Million)
- Fig. 10 Global Lipid Market Value Chain Analysis
- Fig. 11 Lipid Market Dynamics
- Fig. 12 Market Driver Analysis
- Fig. 13 Global Dietary Supplements Market, 2017 - 2021 (USD Million)
- Fig. 14 Market Restraint Analysis
- Fig. 15 Lipid Market: Porter's Analysis
- Fig. 16 Lipid Market: PESTEL Analysis
- Fig. 17 Lipid Market Revenue Share, By Product, 2021 & 2030 (%)
- Fig. 18 Lipid Market Revenue Share, By Phase, 2021 & 2030 (%)
- Fig. 19 Lipid Market Revenue Share, By Application, 2021 & 2030 (%)
- Fig. 20 Lipid Market Revenue Share, By Region, 2021 & 2030 (%)
- Fig. 21 Mexico Pharmaceuticals Market Size , 2016 - 2021 (in USD Million)
- Fig. 22 Lipid Market: Positioning Analysiss
- Fig. 23 Strategic Framework
